Cytoplasmic-targeted parvalbumin blocks the proliferation of multipotent mesenchymal stromal cells in prophase

[1]  M. Toribio,et al.  The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development , 2013, Oncogene.

[2]  D. Gomes,et al.  Cytoplasmic-targeted parvalbumin blocks the proliferation of multipotent mesenchymal stromal cells in prophase , 2013, Stem Cell Research & Therapy.

[3]  Seok-Goo Cho,et al.  Clinical applications of mesenchymal stem cells , 2013, The Korean journal of internal medicine.

[4]  R. S. Wong,et al.  Mesenchymal Stem Cells: Angels or Demons? , 2011, Journal of biomedicine & biotechnology.

[5]  S. Böhm,et al.  Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC , 2011, Cell Communication and Signaling.

[6]  K. Machaca Ca(2+) signaling, genes and the cell cycle. , 2010, Cell calcium.

[7]  D. A. Gomes,et al.  Cytosolic calcium regulates liver regeneration in the rat , 2010, Hepatology.

[8]  M. Krampera,et al.  Human bone marrow and adipose tissue mesenchymal stem cells: a user's guide. , 2010, Stem cells and development.

[9]  C. Thiemermann,et al.  Mesenchymal Stromal Cells: Current Understanding and Clinical Status , 2009, Stem cells.

[10]  Joseph Wagner,et al.  Optimizing mesenchymal stem cell-based therapeutics. , 2009, Current opinion in biotechnology.

[11]  J. Dranoff,et al.  Intracellular calcium signals regulate growth of hepatic stellate cells via specific effects on cell cycle progression. , 2009, Cell calcium.

[12]  A. Uccelli,et al.  Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.

[13]  P. Várnai,et al.  c-Met Must Translocate to the Nucleus to Initiate Calcium Signals*♦ , 2008, Journal of Biological Chemistry.

[14]  M. Paz,et al.  Molecular Characterization of Spontaneous Mesenchymal Stem Cell Transformation , 2008, PloS one.

[15]  M. Leite,et al.  Nucleoplasmic Calcium Is Required for Cell Proliferation* , 2007, Journal of Biological Chemistry.

[16]  Carlo Riccardi,et al.  Analysis of apoptosis by propidium iodide staining and flow cytometry , 2006, Nature Protocols.

[17]  P. Giannoudis,et al.  Biology of mesenchymal stem cells. , 2005, Injury.

[18]  L. Santella,et al.  The cell cycle: a new entry in the field of Ca2+ signaling , 2005, Cellular and Molecular Life Sciences CMLS.

[19]  F. Claas,et al.  Isolation of Mesenchymal Stem Cells of Fetal or Maternal Origin from Human Placenta , 2004, Stem cells.

[20]  L. Munaron,et al.  Intracellular calcium signals and control of cell proliferation: how many mechanisms? , 2004, Journal of cellular and molecular medicine.

[21]  S. Kornbluth,et al.  Phosphorylation of the cyclin b1 cytoplasmic retention sequence by mitogen-activated protein kinase and Plx. , 2003, Molecular cancer research : MCR.

[22]  Catherine G. Takizawa,et al.  Control of mitosis by changes in the subcellular location of cyclin-B1-Cdk1 and Cdc25C. , 2000, Current opinion in cell biology.

[23]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[24]  Hilmar Bading,et al.  Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression , 1997, Nature.

[25]  M. Berridge,et al.  Calcium signalling and cell proliferation , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[26]  T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[27]  K. Machaca Ca(2+) signaling, genes and the cell cycle. , 2011, Cell calcium.

[28]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[29]  R. Mikkelsen,et al.  Induction of apoptotic DNA fragmentation and c-jun downregulation in human myeloid leukemia cells by the permeant Ca2+ chelator BAPTA/AM. , 1995, Oncology research.

[30]  J. Hacker,et al.  Adherence to and cytotoxicity of Escherichia coli for eucaryotic cell lines quantified by MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide). , 1992, Zentralblatt fur Bakteriologie : international journal of medical microbiology.